Oregon Bioscience Association’s Post

When it comes to 'tearing up the traditional biotech playbook' -- we are in the conversation. Nature published an article discussing how bigger and more expensive science requires more extensive collaboration and new funding opportunities. "... it is possible for startups to partner with core facilities at universities in the area to rent time on certain equipment, such as sequencers. One does not need to be in a big city to have this sort of arrangement. The Huck Institute at Pennsylvania State University, for example, runs 12 core labs and offers services for a fee to local companies." Read more about the future of research partnerships and how Penn State University is a great example: https://lnkd.in/gDdnaM83 Penn State Research Huck Institutes of the Life Sciences

Scientists Can Be Entrepreneurs Too! In the scientific community, research and academia are often seen as the natural paths forward. But why stop there? Science can be the bridge between innovation and real-world impact, and biotechnology is the perfect example of that. Take the story of Andreas Laustsen-Kiel from the Technical University of Denmark. Hailing from Tanzania, Andreas recognized snakebite as a critical medical issue. He didn’t just stay within the boundaries of academia—he took it a step further and founded VenomAb, which aimed to develop the world’s first recombinant antivenom against snakebites. By identifying a societal need and demonstrating compelling data, Andreas not only won over investors but also built a sustainable biotech business. Fast forward, and today, he has founded 8 biotech companies! So, how can researchers follow in his footsteps? Identify Societal Problems: Research has the power to change lives. Spot a problem that your work can solve. Commit to Both Fields: Academia and business require dedication. Build a solid reputation in both. Master Communication: Investors need more than just science—they need to see the impact. Be clear, concise, and understand their needs. Collaborate: The right partners and co-founders can accelerate your journey. Embrace New-Age Tools: Stay ahead by leveraging AI and other cutting-edge technologies. Be Humble and Work Hard: Entrepreneurship is a marathon, not a sprint. To my fellow MSc and PhDs—don’t limit yourself to academia. Explore, innovate, and maybe, just maybe, you’ll find yourself at the intersection of science and business. Let’s make an impact together! 🚀 #Biotechnology #Entrepreneurship #ScientificInnovation #TechForGood #BiotechStartups #ResearchersInBusiness #STEMInnovation #PhDLife #ScienceAndBusiness #TechEntrepreneur #AIInScience #FutureOfBiotech #Innovators #ImpactfulResearch #LifeSciences #AcademicEntrepreneur #InnovationLeadership #BiotechEntrepreneur #ResearchToImpact #Startups #DeepTech

🥁 News from Hello Tomorrow Global Summit! We are thrilled to share highlights from the Hello Tomorrow Global Summit 2024, where innovation met impact at the forefront of deep tech. Besides all the new knowledge and technology shared, winning startups of the 9th edition of their Global Startup Challenge were announced 📣 🏆 Grand Winner: tozero was crowned the grand winner, receiving a €100,000 prize for their groundbreaking process that recovers critical materials from all types of lithium-ion batteries. Their innovative approach not only recycles but reintroduces fresh, raw materials back into the supply chain, marking a significant step towards sustainability. 🥈 Second Prize: Robeauté takes home the second prize, awarded by X, the moonshot factory.They are revolutionizing neurosurgery with their new standard device, providing surgeons with seamless access to the brain's most delicate areas. 🥉 Third Prize: Jurata Thin Film took home the third prize for their thin film technology that is transforming the storage and delivery of vaccines and therapeutics worldwide. 🎖️ Special Prize: Cambrium was honored with the special Boston Consulting Group (BCG) prize for their mission to ignite the next wave of material innovation using nature's protein building blocks. In total this year's summit showcased 10 startups (from 4 000 applications!) from diverse industries such as #AdvancedComputing & #Electronics, #Food & #Agriculture, and #SustainableConstruction & #Infrastructure, highlighting the depth of innovation in the global deep tech ecosystem. For more in-depth insights into the winners and a recap of the Hello Tomorrow Global Summit, check out the article on Sesamers! 👉 https://lnkd.in/dxn7r2kZ #HelloTomorrow #Recap #Sustainability #DeepTech #Startups Ben Costantini

Michal Urbánek and Veronika Stepankova introduce CEITEC Innovation Accelerator  🚀 Have a breakthrough idea in nanotech but unsure how to commercialize it? The CEITEC Innovation Accelerator, a partnership between CEITEC - Central European Institute of Technology Brno University of Technology (Vysoké učení technické v Brně) and JIC - podnikání dává smysl Innovation Agency, is here to help scientists transform their research into a thriving business 🎯 The programme solves the traditional conundrum where a scientist is only awarded for solving complex problems, not making prototypes, while a young entrepreneur who needs to make a prototype does not have the support they need, be it financial or otherwise, to turn their idea into a commercial product or service 💡 The programme is open to anyone – from PhD students to fresh graduates to postdocs ✅ Read more about the programme and how to apply in our newly published interview ⬇️ https://lnkd.in/ed6Bxywz #CEITECScience #CEITECInnovationAccelerator CEITEC Nano Research Infrastructure Jan Neuman Halina Jílková #Nanotechnology #Startups #ResearchToMarket #brnoregion

Since yesterday, Gate2Brain has been participating in Research & Innovation (R&I) Week, a flagship event organized by the European Commission in Brussels. As proud recipients of the EIC Accelerator Grant (European Innovation Council and SMEs Executive Agency (EISMEA)- program) , we're thrilled to be part of this event aimed at shaping the future of European research and innovation.   As highlighted by Iliana Ivanova, Commissioner for Innovation, Research, Culture, Education, and Youth, “The R&I Week presents a perfect opportunity to honor our past achievements, evaluate our current status, and envision our future."   📅Today, March 19th, the spotlight will be on the European Innovation Council (EIC) Summit, where high-level discussions, policy debates, and strategic workshops will take center stage, offering invaluable insights and opportunities for researchers and entrepreneurs alike.   Helena Castillo Ecija PhD, MBA, Gate2Brain’s Preclinical and Clinical Project Manager, will be available on-site today. You can schedule a meeting with Helena through 👇 📍the 2024 Research and Innovation Week Networking Platform: https://lnkd.in/dhx-ZVzZ 📍or by reaching her out via email: helena.castillo@gate2brain.com. Get in touch with us if you want to know more about Gate2Brain’s technology to bring medicines beyond barriers.  #synergies #entrepreneurship #biotech #startup #medicinesbeyondbarriers

🌍💡Discover the future at the #Curious2024 - Future Insight Conference! With exclusive offer for 5-HT-Affiliated Startups 💰   As a supporting partner, 5-HT Chemistry & Health is committed to fostering innovation and collaboration in the fields of science and technology. This premier conference promises to offer a glimpse into the future of technology, including health, nutrition, materials, energy, digitalization, artificial intelligence, machine learning, and robotics. 👀 💰 Exclusive Offer for 5-HT-Affiliated Startups: If your startup operates in any of the mentioned fields, submit your abstract for a chance to receive two free tickets to Curious2024. Simply ensure to mention "5-HT" in your 200-word description. Don't miss out on this chance to showcase your innovative solutions and network with industry experts. Submission Deadline: March 31, 2024 Event Dates: July 10-11, 2024 (Mainz & online) For more information and to submit your abstract, visit: https://lnkd.in/d8BVNfWK Let's come together, united by science, to shape a brighter future! 🌍💡 Future Insight e.V. #scienceforgood #Unitedbyscience #Innovation #Chemistry #Healthcare

🎉 Introducing The Biotech Startup Standard! 🎉 Welcome to the inaugural issue of The Biotech Startup Standard, your premier source for insights and guidance in the development of new medicinal products. This magazine was born during a brainstorming session between us at ADRES and a few industry colleagues over coffee. We realized there was a gap in accessible, practical information for biotech startups navigating the complex journey from concept to market. In this first issue, we delve into the critical topic of technology transfer. Articles are written by professionals who know this field inside out. Here are some highlights: 1. Cutting-Edge Insights: Dive into the latest trends and breakthroughs in biotech. Our articles provide actionable insights to help startups thrive. 2. Expert Authors: Our contributors are seasoned professionals who understand the intricacies of tech transfer. Expect well-researched, practical advice. 3. Industry Impact: The magazine bridges the gap between research and commercialization. Share it with your network to empower fellow biotech enthusiasts! 🌟 🔗 Read the full magazine here: The Biotech Startup Standard https://lnkd.in/dRaUVyqF Feel free to share this exciting resource with your network! 🚀💡 #Biotech #Startup #TechTransfer #MedicinalProducts A big 𝐓𝐇𝐀𝐍𝐊𝐒 to these incredible authors and people! Rivka Zaibel Roy Zaibel Dorit Cohen Carmon Tali Aloya, Ph.D. Michal Roll Darron Segall, MHS Michal Zilberberg Elad Mark Tamar Oved Hadar Solomon Hili Rashkovan

𝗕𝗿𝗶𝗱𝗴𝗶𝗻𝗴 𝘁𝗵𝗲 𝗚𝗮𝗽: 𝗙𝗿𝗼𝗺 𝗟𝗮𝗯 𝘁𝗼 𝗠𝗮𝗿𝗸𝗲𝘁 Innovation in science has the potential to transform industries, improve lives, and shape the future. However, many groundbreaking discoveries often stay confined within the lab, unable to reach the broader market where they can make a real impact. Why is that? One of the main challenges in bringing science to market is the 𝗱𝗶𝘀𝗰𝗼𝗻𝗻𝗲𝗰𝘁 𝗯𝗲𝘁𝘄𝗲𝗲𝗻 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗮𝗻𝗱 𝗰𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻. Many scientists focus solely on the technical aspects of their work, overlooking the importance of product development, market needs, and business strategy. Additionally, 𝗳𝘂𝗻𝗱𝗶𝗻𝗴 𝗰𝗼𝗻𝘀𝘁𝗿𝗮𝗶𝗻𝘁𝘀, 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗵𝘂𝗿𝗱𝗹𝗲𝘀, 𝗮𝗻𝗱 𝗮 𝗹𝗮𝗰𝗸 𝗼𝗳 𝗲𝗻𝘁𝗿𝗲𝗽𝗿𝗲𝗻𝗲𝘂𝗿𝗶𝗮𝗹 𝗺𝗶𝗻𝗱𝘀𝗲𝘁 often stall the transition from innovation to real-world application. But it doesn't have to be this way. To overcome these barriers, we need to: 1. 𝗙𝗼𝘀𝘁𝗲𝗿 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻𝘀 between scientists, entrepreneurs, and industry leaders, ensuring that research is driven by real-world needs. 2. Provide 𝗲𝗻𝘁𝗿𝗲𝗽𝗿𝗲𝗻𝗲𝘂𝗿𝗶𝗮𝗹 𝘁𝗿𝗮𝗶𝗻𝗶𝗻𝗴 to researchers, equipping them with the skills necessary to navigate commercialization. 3. Develop 𝘀𝘁𝗿𝗼𝗻𝗴𝗲𝗿 𝗳𝘂𝗻𝗱𝗶𝗻𝗴 𝗲𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺𝘀, encouraging private and public investments that support the journey from lab to market. 4. Streamline 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗳𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸𝘀 to make it easier for scientific innovations to pass through compliance and reach consumers. 5. Cultivate a culture that values 𝘁𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵; research that actively aims to solve real-world problems and is market-ready. By addressing these challenges, we can accelerate the path from discovery to market, ensuring that scientific breakthroughs are not just celebrated within research communities but are also 𝗮𝗰𝗰𝗲𝘀𝘀𝗶𝗯𝗹𝗲, 𝗶𝗺𝗽𝗮𝗰𝘁𝗳𝘂𝗹, 𝗮𝗻𝗱 𝘀𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗹𝗲 in everyday life. Let’s work towards a future where science in the lab seamlessly flows into innovations that benefit society. Bringing science to the market is not just the responsibility of researchers, but of the entire ecosystem. Let me know how you think we can solve this problem!? #InnovationToMarket #TranslationalResearch #ScienceAndEntrepreneurship #BringingScienceToLife #BiotechStartups #LabToMarket #Commercialization #ScienceForImpact #ScienceEntrepreneurs

Key Stakeholders Driving Innovation: The Collaborative Ecosystem of Academic-Industry Partnerships Successful partnerships in biotechnology and tech research rely on a diverse group of stakeholders, each bringing unique strengths and interests. Here’s a breakdown of the key players shaping innovation: 1. Universities: - Home to cutting-edge research universities foster the talents of faculty and students, driving knowledge creation and discovery. - They provide a critical space for early-stage research and a pipeline for talent that will fuel the innovation economy. 2. Industry: - From corporations to start-ups, companies are invested in translating research into practical, market-ready solutions. - R&D departments are crucial for turning academic breakthroughs into scalable technologies and products that benefit society. 3. Government and Funding Agencies: - Governments and funding bodies play a critical role in catalyzing collaboration by providing essential resources, incentives, and frameworks that foster partnerships. - They help de-risk early-stage research, making industry engagement more attractive. 4. Other Intermediaries: - NGOs, innovation hubs, and incubators help bridge gaps by providing infrastructure, networking, and mentorship, ensuring that innovation thrives at every stage of the process. - These organizations foster a culture of entrepreneurship and support the growth of new ventures. Collaboration among these stakeholders is crucial to translating research into impact, accelerating product development, and shaping the future of industries like biotech and tech. #InnovationEcosystem #AcademicPartnerships #BiotechResearch #IndustryCollaboration #STEM #R&D #GovernmentFunding #Incubators #TechInnovation #CollaborationMatters

Excited to unveil our latest interactive map on 2023 biotech funding by location (within the article below), showcasing real-time investments across the globe. After crunching all of the biotech startups that attracted funding in 2023 in Crunchbase, mapping them reveals the continued resilience of the U.S. biotech industry despite significant headwinds. China-based companies got more funding on average, but fewer companies there won funding last year. European firms are showing a strong capacity for attracting high-value investments, but the average funding amount was notably lower than their counterparts in the U.S. and China.